首页> 外国专利> APPLICATION OF DGCR8 IN PREPARATION OF PRODUCT FOR TREATING AND/OR PREVENTING OSTEOARTHRITIS IN ANIMALS

APPLICATION OF DGCR8 IN PREPARATION OF PRODUCT FOR TREATING AND/OR PREVENTING OSTEOARTHRITIS IN ANIMALS

机译:DGCR8在制备用于治疗和/或预防动物骨关节炎的产品中的应用

摘要

Disclosed by the present invention is an application of DGCR8 in the preparation of a product for treating and/or preventing osteoarthritis in animals. The present invention finds that DGCR8 has the following functions: treating and/or preventing osteoarthritis in animals; treating and/or preventing animal osteoarthritis induced by severing the anterior cruciate ligament or osteoarthritis caused by physiological aging; delaying the aging of mesenchymal stem cells; delaying the replicative aging of mesenchymal stem cells; and delaying the pathological aging of mesenchymal stem cells. Experiments have shown that DGCR8 has a clear function of delaying the aging of mesenchymal stem cells, and has a clear therapeutic effect on osteoarthritis, thus providing novel ideas for the development of gene therapies used for osteoarthritis and expanding the selectable range of clinical gene therapies.
机译:本发明公开了DGCR8在制备用于治疗和/或预防动物骨关节炎的产品中的应用。本发明发现DGCR8具有以下功能:治疗和/或预防动物的骨关节炎;和治疗和/或预防由于生理老化而切断前十字韧带或骨关节炎引起的动物骨关节炎;延缓间充质干细胞的衰老;延缓间充质干细胞的复制性衰老;并延缓间充质干细胞的病理衰老。实验表明,DGCR8具有明显的延迟间充质干细胞衰老的功能,对骨关节炎具有明显的治疗作用,从而为开发用于骨关节炎的基因疗法和扩大临床基因疗法的选择范围提供了新思路。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号